Differential expression of the melatonin receptor in human monocytes

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1191-1197

  Barjavel, Marc J ^a   Mamdouh, Zahra ^a   Raghbate, Nadjibe ^a   Bakouche, Ouahid ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MELATONIN; PINEAL BODY HORMONE; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; LIPOPOLYSACCHARIDES; MELATONIN; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; TIME FACTORS;

EID: 0031940492     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Blalock, J. E. 1984. Relationships between neuroendocrine hormones and lymphokines. Lymphokines 9:1.
2. Rothwell, N. J. 1991. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12:430.
3. Maestroni, G. J. 1995. T-helper-2 lymphocytes as a peripheral target of melatonin J. Pineal Res. 18:84.
4. Zylinska, K., J. Komorowski, T. Robak, S. Mucha, and H. Stepien. 1995. Effect of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor on melatonin secretion in rats in vivo and in vitro studies. J. Neuroimmunol. 56:187.
5. Maclean, D., and S. Reichlin. 1981. Neuroendocrinology and the immune process. In Psychoneuroendocrimmunology. R. Ader, ed. Academic Press, New York, p. 475.
6. Hall, D., and A. L. Goldstein. 1981. Neurotransmitters and the immune system. In Psychoneuroendocrimmunology. R. Ader, ed. Academic Press, New York, p. 521.
7. Koff, W. C., and M. A. Dunegan. 1985. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol. 135:350.
8. Morrey, K. M., J. A. McLachlan, C. D. Serkin, and O. Bakouche. 1994. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153:2671.
9. Guerrero, J. M., and R. J. Reiter. 1992. A brief survey of pineal gland-immune system interrelationships. Endocr. Res. 18:91.
10. Poon, A. M., Z. M. Liu, C. S. Pang, G. M. Brown, and S. F. Pang. 1994. Evidence for a direct action of melatonin on the immune system. Biol. Signals 3:107.
11. Wajs, E., E. Kutoh, and D. Gupta. 1995. Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat. Eur. J. Endocrinol. 133:754.
12. del Gobbo, V., V. Libri, N. Villani, R. Calio, and G. Nistico. 1989. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int. J. Immunopharmacol. 11:567.
13. Giordano, M., and M. S. Palermo. 1991. Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity. J. Pineal Res. 10:117.
14. Pioli, C., M. C. Caroleo, G. Nistico, and G. Doria. 1993. Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int. J. Immunopharmacol. 15:463.
15. Konakchieva, R., S. Kyurkchiev, I. Kehayov, P. Taushanova, and L. Kanchev. 1995. Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J. Neuroimmunol. 63:125.
16. Lissoni, P., S. Pittalis, F. Brivio, E. Tisi, F. Rovelli, A. Ardizzoia, S. Barni, G. Tancini, G. Giudici, A. Biondi, and et al. 1993. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. Cancer 71:2076.
17. Lopez-Gonzalez, M. A., J. R. Calvo, C. Osuna, A. Rubio, and J. M. Guerrero. 1992. Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes. Neurosci. Lett. 136:150.
18. Lissoni, P., S. Barni, G. Tancini, F. Brivio, E. Tisi, B. Zubelewicz, and R. Braczkowski. 1994. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin. J. Biol. Regul. Homeostatic Agents 8:126.
19. Waldhauser, F., B. Ehrhart, and E. Forster. 1993. Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions. Experientia 49:671.
20. Maestroni, G. J. 1993. The immunoneuroendocrine role of melatonin. J. Pineal Res. 14:1.
21. Maestroni, G. J., V. Covacci, and A. Conti. 1994. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res. 54:2429.
22. Withyakumnarkul B, K. O. Nonaka, C. Santana, A. M. Attia, and R. J. Reiter. 1990. Interferon γ modulates melatonin production in rat pineal glands in organ culture. J. Interferon Res. 10:403.
23. Withyakumnarkul, B., K. O. Nonaka, A. M. Attia, and R. J. Reiter. 1990. Changes in indole metabolism in organ cultured rat pineal gland induced by interferon. J. Pineal Res. 8:313.
24. Lissoni, P., A. Ardizzoia, E. Tisi, F. Rossini, S. Barni, G. Tancini, A. Conti, and G. J. Maestroni. 1993. Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2. J. Biol. Regul. Homeostatic Agents 7:34.
25. Lissoni, P., S. Barni, M. Cazzaniga, A. Ardizzoia, F. Rovelli, F. Brivio, and G. Tancini 1994:. Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone. Oncology 51:344.
26. Barni, S., P. Lissoni, M. Cazzaniga, A. Ardizzoia, F. Paolorossi, F. Brivio, M. Perego, G. Tancini, A. Conti, and G. Maestroni. 1992. Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma. Tumori 78:383.
27. Buswell, R. S. 1975. Letter: the pineal and neoplasia. Lancet 1:34.
28. Das Gupta, T. K., and J. Terz. 1967. Influence of pineal gland on the growth and spread of melanoma in the hamster. Cancer Res. 27:1306.
29. Aubert, C. P. Janiaud, and J. Lecalvez. 1980. Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J. Neural Transm. 47:121.
30. Lissoni, P., S. Barni, S. Crispino, G. Tancini, and F. Fraschini. 1989. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur. J. Cancer Clin. Oncol. 25:789.
31. Lissoni, P., S. Barni, G. Tancini, V. Fossati, and F. Frigerio. 1994. Pineal-opioid system interactions in the control of immunoinflammatory responses. Ann. NY Acad. Sci. 741:191.
32. 125I]iodomelatonin by spleen membrane preparations of chicken. J. Pineal Res. 12:167.
33. 125I]-labelled iodomelatonin in the duck thymus. Biol. Signals 1:250.
34. 3H]-melatonin in human platelets. J. Pineal Res. 13:60.
35. Lopez-Gonzalez, M. A., J. R. Calvo, J. J. Segura, and J. M. Guerrero. 1993. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnol. Ther. 4:253.
36. Lopez-Gonzalez, M. A., J. R. Calvo, C. Osuna, and J. M. Guerrero. 1992. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP. J. Pineal Res. 12:97.
37. Lopez-Gonzalez, M. A., J. R. Calvo, C. Osuna, A. Rubio, and J. M. Guerrero. 1992. Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes. J. Pineal Res. 12:174.
38. 125I)iodomelatonin binding sites in rat adrenals: pharmacological characteristics and subcellular distribution. Life Sci. 51:647.
39. Cohen, M., D. Roselle, B. Chabner, T. J. Schmidt, and M. Lippman. 1978. Evidence for a cytoplasmic melatonin receptor. Nature 274:894.
40. McLachlan, J. A., C. D. Serkin, and O. Bakouche. 1996. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156:328.
41. McLachlan, J. A., C. D. Serkin, K. M. Morrey, and O. Bakouche. 1995. Antitumoral properties of aged human monocytes. J. Immunol. 154:832.
42. Krakauer, T. 1993. A sensitive, specific immunobioassay for quantitation of human interleukin 6. J. Immunoassay 14:267.
43. Proudfoot, A. E., S. C. Brown, A. R. Bernard, J. Y. Bonnefoy, and E. H. Kawashima. 1993. Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal. J. Protein Chem. 12:489.
44. Topley, N., A. Jorres, W. Luttmann, M. M. Petersen, M. J. Lang, K. H. Thierauch, C. Muller, G. A. Coles, M. Davies, and J. D. Williams. 1993. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int. 43:226.
45. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
46. Perera, P., S. N. Vogel, G. R. Detore, A. Haziot, and S. M. Goyert. 1997. CD14-dependent and CD14 independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with LPS or taxol. J. Immunol. 158:422.
47. Meng, F., and C. A. Lowell. 1997. LPS-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr and Lyn. J. Exp. Med. 185:1661.
48. Hellstrand, K., and S. Hermodsson. 1990. Monocyte-mediated suppression of IL-2-induced NK-cell activation: regulation by 5-HTI A-type serotonin receptors. Scand. J. Immunol. 32:183.
49. Finocchiaro, L. M., E. S. Arzt, S. Fernandez-Castelo, M. Criscuolo, S. Finkielman, and V. E. Nahmod. 1988. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. J. Interferon Res. 8:705.
50. 125I]iodomelatonin binding in the chicken lung, brain and kidney: hypothesis of different subtypes of high affinity melatonin receptors. Biol. Signals 2:27.
51. Steinhilber, D., M. Brungs, O. Werz, I. Wiesenberg, C. Danielsson, J. P. Kahlen, S. Nayeri, M. Schrader, and C. Carlberg. 1995. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270:7037.
52. Janson, R. W., F. G. Joslin, and W. P. Arend. 1990. The effects of differentiating agents on IL-1 beta production in cultured human monocytes. J. Immunol. 145:2161.
53. Weaver, D. R., S. A. Rivkees, and S. M. Reppert. 1989. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J. Neurosci. 9:2581.